Pmv Pharmaceuticals, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
PMV Pharmaceuticals, Inc. has announced its 2026 Annual Meeting of Stockholders, to be held virtually on June 4, 2026, with key proposals including director elections and auditor ratification.
NASDAQ
PMV Pharmaceuticals, Inc. has filed a definitive proxy statement with the SEC.
NASDAQ
PMV Pharmaceuticals will hold its 2025 annual meeting of stockholders virtually on June 5, 2025, to vote on director elections, executive compensation, and the ratification of the company's independent accounting firm.
NASDAQ
PMV Pharmaceuticals, Inc. has filed a definitive proxy statement with the SEC.
NASDAQ
PMV Pharmaceuticals will hold its 2024 annual meeting of stockholders virtually on June 6, 2024, to vote on director elections, executive compensation, and auditor ratification.